Australian Financial Review article
The Australian Financial Review wrote an article about Ecofibre’s upcoming $300m IPO on the Australian Stock Exchange. The article is titled: “Barry Lambert back with $300m float”.
Author: ecofibrecom
The Australian features Barry Lambert in the leadup to the IPO
The Australian published an article about our founder Barry Lambert: “Lambert seeks hemp funding”.
Her Life Magazine announces Ananda Hemp as the leader in the CBD market
Her Life Magazine’s article showcases Ecofibre’s Chief Science Officer, Dr Alex Capano, and Ananda Hemp as the leader in the CBD market. The article discusses the market, why another company distributes Ananda Hemp products, and how CBD can help various health problems.
Fashionista uncovers the size of the CBD market and various wellness product suppliers
A bit controversial, featuring a back-and-forth between our own Dr Alex Capano representing thoughts on CBD and hemp-derived medical effects, and another doctor from a medical marijuana clinic representing thoughts on marijuana’s medical effects. Discussion around various marketplaces supplying CBD and their market size.
BonAppetit discusses Ecofibre’s product Dusk and it’s impact on sleep
A light discussion by BonAppetit on how CBD can have positive effects on people with sleep disorders or irregular sleep. Read the full article on the BonAppetit website here: Read the full article
Gossamer does a deep dive
Gossamer dig in and uncover lots of details about the life of Alex Capano, Ecofibre’s Chief Science Officer. How she came to study cannabinoid science, the issues she sees across the medical spectrum and the social issues surrounding use of cannabis-derived products.
Ananda Hemp mentioned in Net-a-porter article about feeling calm
Net-a-porter feature Alex Capano and Ananda Hemp in their article about getting a clearer state of mind, delving into which vitamins, natural food sources and CBD are good for you.
This Plant Product Is Growing Prolific Profits at Independent Pharmacies
Have you heard of independent pharmacy’s latest cash cow? Or more appropriately, cash crop? Cannabidiol (CBD), a non-psychoactive compound of cannabis, is growing profits at a prolific pace among retailers across the country. The natural product purports a bevy of therapeutic benefits without the requirement of a prescription or the risk of addiction. And consumers […]
You’re Probably Taking CBD Oil Wrong
When it comes to the cannabidiol market, it’s hard to know which brands are for real and which are just blowing smoke. Here are the ABC’S of CBD. Read the full article
DEA Plans to Quintuple Amount of Cannabis Grown for Research
The U.S. Department of Justice and the U.S. Drug Enforcement Administration (DEA) have proposed to significantly increase the amount of cannabis that can legally grow in the U.S. for research purposes and reduce the number of opioids that are manufactured in the nation in 2019. The 2019 Aggregate Production Quota for Schedule I and II […]